Department of Gastroenterology of Hospital Universitario de Canarias, Instituto Universitario de Tecnologías Biomédicas (ITB) & Centro de Investigación Biomédica de Canarias (CIBICAN), Universidad de La Laguna, Spain.
Department of Gastroenterology of Hospital Universitario de Canarias, Instituto Universitario de Tecnologías Biomédicas (ITB) & Centro de Investigación Biomédica de Canarias (CIBICAN), Universidad de La Laguna, Spain.
Best Pract Res Clin Gastroenterol. 2023 Oct;66:101838. doi: 10.1016/j.bpg.2023.101838. Epub 2023 May 14.
Colonoscopy is the cornerstone examination for colorectal cancer (CRC) screening and it is recommended as the first examination in the context of individuals with high risk of CRC development. Thereby, this examination is of choice in the setting of patients with hereditary CRC syndromes or in patients with long-standing inflammatory bowel disease with colon involvement. However, its role is less clear in the average risk-risk population and in patients with family history of CRC not linked to hereditary CRC syndromes. Despite this, current guidelines, include colonoscopy as alternative for CRC screening either in average risk population with the same evidence level that other screening strategies or in the familial risk population. The present manuscript reviews the clinical evidence on the role of colonoscopy in preventing CRC in different screening settings.
结肠镜检查是结直肠癌(CRC)筛查的基石检查,建议将其作为 CRC 高危人群的首选检查。因此,在遗传性 CRC 综合征患者或累及结肠的长期炎症性肠病患者中,该检查是首选。然而,在平均风险人群和有家族史但与遗传性 CRC 综合征无关的 CRC 患者中,其作用不太明确。尽管如此,目前的指南仍将结肠镜检查作为 CRC 筛查的替代方法,包括在具有与其他筛查策略相同证据水平的平均风险人群中,或在家族性风险人群中。本文综述了结肠镜检查在不同筛查环境下预防 CRC 的临床证据。